A S Sousa1, R S Guerra2,3, I Fonseca4, F Pichel4, S Ferreira5, T F Amaral1,3. 1. Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto, Porto, Portugal. 2. Departamento de Bioquímica da Faculdade de Medicina, Universidade do Porto, Porto, Portugal. 3. UISPA-INEGI, Faculdade de Engenharia, Universidade do Porto, Porto, Portugal. 4. Serviço de Nutrição e Alimentação, Centro Hospitalar do Porto, Porto, Portugal. 5. Centro Hospitalar do Porto, Porto, Portugal.
Abstract
BACKGROUND/ OBJECTIVES: This study aims to increase knowledge regarding the association of sarcopenia with hospitalization costs among a wide-ranging sample of adult hospitalized patients. SUBJECTS/ METHODS: A prospective study was conducted among hospitalized adult patients. Sarcopenia was identified according to the European Working Group on Sarcopenia in Older People, as low muscle mass, assessed by bioelectrical impedance analysis and low muscle function evaluated by handgrip strength. Hospitalization cost was calculated for each patient based on discharge diagnosis-related group codes and determined on the basis of a relative weight value. Costs were defined as the percentage of deviation from the cost of a patient with a relative weight equal to one. Multivariable linear regression models were performed to identify the factors independently associated with hospitalization costs. RESULTS: A total of 656 hospitalized patients aged ⩾18 years (24.2% sarcopenic) composed the study sample. Sarcopenia increased hospitalization costs by [euro ]1240 (95% confidence interval (CI): [euro ]596-1887) for patients aged <65 years and [euro ]721 (95% CI: [euro ]13-1429) for patients aged ⩾65 years. Sarcopenic overweight was related to an increase in hospitalization costs of [euro ]884 (95% CI: [euro ]295-1476). CONCLUSIONS: Sarcopenia is independently related to hospitalization costs. This condition is estimated to increase hospitalization costs by 58.5% for patients aged <65 years and 34% for patients aged ⩾65 years.
BACKGROUND/ OBJECTIVES: This study aims to increase knowledge regarding the association of sarcopenia with hospitalization costs among a wide-ranging sample of adult hospitalized patients. SUBJECTS/ METHODS: A prospective study was conducted among hospitalized adult patients. Sarcopenia was identified according to the European Working Group on Sarcopenia in Older People, as low muscle mass, assessed by bioelectrical impedance analysis and low muscle function evaluated by handgrip strength. Hospitalization cost was calculated for each patient based on discharge diagnosis-related group codes and determined on the basis of a relative weight value. Costs were defined as the percentage of deviation from the cost of a patient with a relative weight equal to one. Multivariable linear regression models were performed to identify the factors independently associated with hospitalization costs. RESULTS: A total of 656 hospitalized patients aged ⩾18 years (24.2% sarcopenic) composed the study sample. Sarcopenia increased hospitalization costs by [euro ]1240 (95% confidence interval (CI): [euro ]596-1887) for patients aged <65 years and [euro ]721 (95% CI: [euro ]13-1429) for patients aged ⩾65 years. Sarcopenic overweight was related to an increase in hospitalization costs of [euro ]884 (95% CI: [euro ]295-1476). CONCLUSIONS:Sarcopenia is independently related to hospitalization costs. This condition is estimated to increase hospitalization costs by 58.5% for patients aged <65 years and 34% for patients aged ⩾65 years.
Authors: Karen Freijer; Siok Swan Tan; Marc A Koopmanschap; Judith M M Meijers; Ruud J G Halfens; Mark J C Nuijten Journal: Clin Nutr Date: 2012-07-10 Impact factor: 7.324
Authors: Peter S Kirk; Jeffrey F Friedman; David C Cron; Michael N Terjimanian; Stewart C Wang; Darrell A Campbell; Michael J Englesbe; Nicole L Werner Journal: J Surg Res Date: 2015-04-30 Impact factor: 2.192
Authors: Andrea P Rossi; Francesco Fantin; Rocco Micciolo; Monica Bertocchi; Paolo Bertassello; Valeria Zanandrea; Alessandra Zivelonghi; Luisa Bissoli; Mauro Zamboni Journal: J Am Med Dir Assoc Date: 2014-02-06 Impact factor: 4.669
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Hannah M Davis; Alyson L Essex; Sinai Valdez; Padmini J Deosthale; Mohammad W Aref; Matthew R Allen; Andrea Bonetto; Lilian I Plotkin Journal: Bone Date: 2019-04-24 Impact factor: 4.398
Authors: Vitor H F Oliveira; Ana L Borsari; Allison R Webel; Kristine M Erlandson; Rafael Deminice Journal: Eur J Clin Nutr Date: 2020-04-27 Impact factor: 4.016
Authors: Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield Journal: Ann Med Date: 2018-09-12 Impact factor: 4.709
Authors: Tyler B Waltz; Elayne M Fivenson; Marya Morevati; Chuanhao Li; Kevin G Becker; Vilhelm A Bohr; Evandro F Fang Journal: Curr Med Chem Date: 2018 Impact factor: 4.530
Authors: S M Robinson; J Y Reginster; R Rizzoli; S C Shaw; J A Kanis; I Bautmans; H Bischoff-Ferrari; O Bruyère; M Cesari; B Dawson-Hughes; R A Fielding; J M Kaufman; F Landi; V Malafarina; Y Rolland; L J van Loon; B Vellas; M Visser; C Cooper Journal: Clin Nutr Date: 2017-08-24 Impact factor: 7.324
Authors: Alistair J Monteyne; Mandy V Dunlop; David J Machin; Mariana O C Coelho; George F Pavis; Craig Porter; Andrew J Murton; Doaa R Abdelrahman; Marlou L Dirks; Francis B Stephens; Benjamin T Wall Journal: Br J Nutr Date: 2020-11-11 Impact factor: 3.718